Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trialIldiko Lingvay, Rory J. McCrimmon|The Lancet Diabetes & Endocrinology|2019Cited by 282
Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetesAlison D. McNeilly, Rory J. McCrimmon|Diabetologia|2023Cited by 12